Featured Research

from universities, journals, and other organizations

Study Discloses New Component Of Cells' Built-In Suicide Program

Date:
April 23, 1999
Source:
Dana-Farber Cancer Institute
Summary:
Scientists at Dana-Farber Cancer Institute and Duke University Medical Center have uncovered a new portion of the circuitry that controls the natural death of cells - a malfunction of which may underlie diseases ranging from cancer to heart disease to autoimmune disorders.

Research Finding Opens Uncharted Area of Cell Life/Death

Boston -- Scientists at Dana-Farber Cancer Institute and Duke University Medical Center have uncovered a new portion of the circuitry that controls the natural death of cells - a malfunction of which may underlie diseases ranging from cancer to heart disease to autoimmune disorders.

The study, published in the April 23 issue of Science, not only opens a previously uncharted area of cell life to scientific study, but also identifies new targets for therapies that can return diseased cells to the normal path of mortality.

"This research elucidates how cells naturally commit suicide, or undergo `apoptosis,'" says Joan Mannick, M.D., of Dana-Farber, who co-authored the study with Jonathan Stamler, M.D., a Howard Hughes Medical Institute researcher at Duke. "We now know that in addition to the controls on apoptosis that have already been identified, there's another control system that works in unison with them."

The study focuses on a protein called caspase which is an essential component of cells' suicide machinery.

In the laboratory, chemical bundles of nitric oxide (NO) can be made to attach to, or become detached from, caspase. This coupling and decoupling can have a powerful effect on a protein's activity. When caspase proteins are bound to NO, they're essentially handcuffed from performing their normal function. When the NO is removed, cell death can proceed.

But whether such binding and unbinding occurs in living cells - and what it would mean if it does - has been unclear. In fact, only a few types of proteins have been found to be attached to NO in cells.

The current study involved human lymphocytes, white blood cells that help provide immune protection against disease. Such cells perform a variety of functions, but one thing they don't do is produce much NO.

Mannick and her colleagues extracted caspase from lymphocytes that were in a "resting" state - that is, not yet embarked on apoptosis. To their surprise, they found the protein had an NO group attached.

"The fact that we found NO attached to proteins even in cells that produce very little of it indicates that NO may help regulate protein function in a much broader range of cells than was previously appreciated," Mannick says.

The nature of its role became clear when researchers triggered the cells' apoptosis mechanism. The caspase proteins collected from the apoptotic cells had lost their NO.

"This is the first time that NO has been found to attach and detach from caspase in living cells," Mannick says. "It represents a new control mechanism for cell death and, potentially, a new mechanism for controlling other cell functions."

Researchers were able to detect the presence or absence of NO thanks to technology developed by Stamler and his colleagues at Duke. The Duke team has developed new techniques which make it possible to find minute amounts of NO within cells.

Previous work by the Stamler lab has shown that NO represents a key on-off switch for a variety of cell functions. "The new study confirms that apoptosis is one of them," Stamler says. Besides demonstrating that the control system for apoptosis has a previously unknown layer of complexity, the new study may offer new prospects for therapy.

"Defects in apoptosis contribute not only to cancer, in which cells are blocked from committing suicide, but also in conditions such as stroke and neurodegenerative diseases, in which cells die too readily," Stamler says. "Knowing more about the system that controls apoptosis provides new opportunities for therapies aimed at correcting the system when it goes awry."


Story Source:

The above story is based on materials provided by Dana-Farber Cancer Institute. Note: Materials may be edited for content and length.


Cite This Page:

Dana-Farber Cancer Institute. "Study Discloses New Component Of Cells' Built-In Suicide Program." ScienceDaily. ScienceDaily, 23 April 1999. <www.sciencedaily.com/releases/1999/04/990423073448.htm>.
Dana-Farber Cancer Institute. (1999, April 23). Study Discloses New Component Of Cells' Built-In Suicide Program. ScienceDaily. Retrieved August 22, 2014 from www.sciencedaily.com/releases/1999/04/990423073448.htm
Dana-Farber Cancer Institute. "Study Discloses New Component Of Cells' Built-In Suicide Program." ScienceDaily. www.sciencedaily.com/releases/1999/04/990423073448.htm (accessed August 22, 2014).

Share This




More Health & Medicine News

Friday, August 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins